Literature DB >> 20191498

Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review.

Lilian H D van Tuyl1, David T Felson, George Wells, Josef Smolen, Bin Zhang, Maarten Boers.   

Abstract

OBJECTIVE: Remission is rapidly becoming a key end point in rheumatoid arthritis (RA) clinical trials, but its definition is not satisfactory. Although it is generally believed that achieving a state of remission will lead to better structural outcome, this has not been studied systematically. As part of an undertaking to redefine remission, the current review describes the relationship between remission and long-term structural outcome.
METHODS: A systematic literature search of PubMed, EMBase, and The Cochrane Library intersected 3 groups of terms: RA, remission, and long-term outcome. The search identified 1,138 records, of which 14 were relevant to the research question.
RESULTS: All of the studies included in this review showed a relationship between remission and long-term structural damage or disability. Patients that achieved a state of remission, defined in various ways, showed less deterioration of function and radiographic progression compared with patients who did not reach a state of remission.
CONCLUSION: Patients who achieved a state of remission were less likely to show deterioration of function and radiographic progression compared with patients who did not reach a state of remission.

Entities:  

Mesh:

Year:  2010        PMID: 20191498      PMCID: PMC2905735          DOI: 10.1002/acr.20021

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  32 in total

1.  Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Authors:  Josef S Smolen; Andre Beaulieu; Andrea Rubbert-Roth; Cesar Ramos-Remus; Josef Rovensky; Emma Alecock; Thasia Woodworth; Rieke Alten
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

2.  Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.

Authors:  L H D van Tuyl; W F Lems; A E Voskuyl; P J S M Kerstens; P Garnero; B A C Dijkmans; M Boers
Journal:  Ann Rheum Dis       Date:  2008-07-14       Impact factor: 19.103

3.  The use of databases for quality assessment in rheumatoid arthritis.

Authors:  T A Stamm; D Aletaha; S Pflugbeil; T Kapral; K Montag; K P Machold; J S Smolen
Journal:  Clin Exp Rheumatol       Date:  2007 Nov-Dec       Impact factor: 4.473

4.  Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study.

Authors:  I Hafström; K Albertsson; A Boonen; D van der Heijde; R Landewé; B Svensson
Journal:  Ann Rheum Dis       Date:  2008-04-17       Impact factor: 19.103

5.  Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade.

Authors:  J S Smolen; C Han; D M F M van der Heijde; P Emery; J M Bathon; E Keystone; R N Maini; J R Kalden; D Aletaha; D Baker; J Han; M Bala; E W St Clair
Journal:  Ann Rheum Dis       Date:  2008-07-01       Impact factor: 19.103

6.  Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.

Authors:  Paul Emery; Ferdinand C Breedveld; Stephen Hall; Patrick Durez; David J Chang; Deborah Robertson; Amitabh Singh; Ronald D Pedersen; Andrew S Koenig; Bruce Freundlich
Journal:  Lancet       Date:  2008-07-16       Impact factor: 79.321

7.  Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries.

Authors:  Tuulikki Sokka; Merete Lund Hetland; Heidi Mäkinen; Hannu Kautiainen; Kim Hørslev-Petersen; Reijo K Luukkainen; Bernard Combe; Humeira Badsha; Alexandros A Drosos; Joe Devlin; Gianfranco Ferraccioli; Alessia Morelli; Monique Hoekstra; Maria Majdan; Stefan Sadkiewicz; Miguel Belmonte; Ann-Carin Holmqvist; Ernest Choy; Gerd R Burmester; Recep Tunc; Aleksander Dimić; Jovan Nedović; Aleksandra Stanković; Martin Bergman; Sergio Toloza; Theodore Pincus
Journal:  Arthritis Rheum       Date:  2008-09

8.  Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.

Authors:  D van der Heijde; L Klareskog; R Landewé; G A W Bruyn; A Cantagrel; P Durez; G Herrero-Beaumont; Y Molad; C Codreanu; G Valentini; R Zahora; R Pedersen; D MacPeek; J Wajdula; S Fatenejad
Journal:  Arthritis Rheum       Date:  2007-12

9.  An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis.

Authors:  A K Brown; P G Conaghan; Z Karim; M A Quinn; K Ikeda; C G Peterfy; E Hensor; R J Wakefield; P J O'Connor; P Emery
Journal:  Arthritis Rheum       Date:  2008-10

10.  IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial.

Authors:  P Emery; E Keystone; H P Tony; A Cantagrel; R van Vollenhoven; A Sanchez; E Alecock; J Lee; J Kremer
Journal:  Ann Rheum Dis       Date:  2008-07-14       Impact factor: 19.103

View more
  24 in total

Review 1.  Radiographic scoring methods in rheumatoid arthritis and psoriatic arthritis.

Authors:  Fausto Salaffi; Marina Carotti; Giacomo Beci; Marco Di Carlo; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2019-02-09       Impact factor: 3.469

2.  Major trends in the manifestations and treatment of rheumatoid arthritis in a multiethnic cohort in Singapore.

Authors:  Ee Tzun Koh; Justina Wei Lynn Tan; Bernard Yu-Hor Thong; Cheng Lay Teh; Tsui Yee Lian; Weng Giap Law; Arul Earnest; Kok Ooi Kong; Tang Ching Lau; Yew Kuang Cheng; Hwee Siew Howe; Wern Hui Yong; Faith Li-Ann Chia; Hiok Hee Chng; Khai Pang Leong
Journal:  Rheumatol Int       Date:  2012-12-28       Impact factor: 2.631

3.  Influence of the different "patient global assessment" formulations on disease activity score by different indices in rheumatoid arthritis.

Authors:  Ricardo J O Ferreira; Gisela Eugénio; Mwidimi Ndosi; Cristiana Silva; Catarina Medeiros; Cátia Duarte; J A P da Silva
Journal:  Clin Rheumatol       Date:  2018-03-10       Impact factor: 2.980

Review 4.  [New options for the practice : Update S1/S2 guidelines on rheumatoid arthritis?]

Authors:  M Schneider
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

Review 5.  [Treat-to-target from the perspective of office-based rheumatology].

Authors:  K Krüger; K Karberg
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

6.  A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis.

Authors:  Eugenio de Miguel; Angela Pecondón-Español; Manuel Castaño-Sánchez; Alfonso Corrales; Ricardo Gutierrez-Polo; Manuel Rodriguez-Gomez; Jose A Pinto-Tasende; Jose L Rivas; José Ivorra-Cortés
Journal:  Rheumatol Int       Date:  2017-04-07       Impact factor: 2.631

Review 7.  Assessing rheumatoid arthritis disease activity with ultrasound.

Authors:  Rafael Mendonça da Silva Chakr; José Alexandre Mendonça; Claiton Viegas Brenol; Ricardo Machado Xavier; João Carlos Tavares Brenol
Journal:  Clin Rheumatol       Date:  2013-05-23       Impact factor: 2.980

Review 8.  Rheumatoid arthritis--early diagnosis and disease management.

Authors:  Matthias Schneider; Klaus Krüger
Journal:  Dtsch Arztebl Int       Date:  2013-07-08       Impact factor: 5.594

9.  American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.

Authors:  David T Felson; Josef S Smolen; George Wells; Bin Zhang; Lilian H D van Tuyl; Julia Funovits; Daniel Aletaha; Cornelia F Allaart; Joan Bathon; Stefano Bombardieri; Peter Brooks; Andrew Brown; Marco Matucci-Cerinic; Hyon Choi; Bernard Combe; Maarten de Wit; Maxime Dougados; Paul Emery; Daniel Furst; Juan Gomez-Reino; Gillian Hawker; Edward Keystone; Dinesh Khanna; John Kirwan; Tore K Kvien; Robert Landewé; Joachim Listing; Kaleb Michaud; Emilio Martin-Mola; Pamela Montie; Theodore Pincus; Pamela Richards; Jeffrey N Siegel; Lee S Simon; Tuulikki Sokka; Vibeke Strand; Peter Tugwell; Alan Tyndall; Desirée van der Heijde; Suzan Verstappen; Barbara White; Frederick Wolfe; Angela Zink; Maarten Boers
Journal:  Arthritis Rheum       Date:  2011-03

10.  Blood monocyte chemotactic protein-1 (MCP-1) and adapted disease activity Score28-MCP-1: favorable indicators for rheumatoid arthritis activity.

Authors:  Lieh-bang Liou; Wen-pin Tsai; Chee J Chang; Wan-ju Chao; Meng-hsin Chen
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.